Farmasiet AS

913 379 721 ↗Retail sale of pharmaceutical products
identity
AS · est 2014OsloParent · 1 subsidiarywas KOMPLETT APOTEK AS →2019
Brreg · companies
Employees134
CEO · since2021-11-19Elisabeth Haug
Chair · since2025-09-05Jonas Petter Sundberg
  • 2026-03-13: 118
  • 2026-04-16: 119
  • 2026-05-14: 125
  • 2026-06-16: 128
  • 2026-07-17: 132
  • 2026-07-25: 132
  • 2026-08-13: 134
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
8 registered roles
Daglig lederElisabeth Haug2021-11-19
Styrets lederJonas Petter Sundberg Multiple boards2025-09-05
StyremedlemSilje Digerud2025-09-05
StyremedlemKristin Haram Førde Multiple boards2025-09-05
StyremedlemChristian Jebsen Multiple boards2025-09-05
StyremedlemMarianne Kristine Arnesen Eskeland Multiple boards2025-09-05
StyremedlemHenriette Hessen Multiple boards2025-09-05
VaramedlemNils Andreas Foldal Multiple boards2025-09-05
register ledger · people
2026-08-13regemployees_change: employees132 -> 134
2026-07-25regemployees_change: employees128 -> 132
2026-07-17regemployee_change: antallAnsatte128 -> 132
2026-06-16regemployee_change: antallAnsatte125 -> 128
2026-05-14regemployee_change: antallAnsatte119 -> 125
2026-04-16regemployee_change: antallAnsatte118 -> 119
2026-03-13regemployee_change: antallAnsatte115 -> 118
NOK, amounts in thousands
20242025
Revenue778 1881 022 144
Operating result−49 598−642
Result before tax−58 658−11 278
Net result−58 6581 592
Total assets198 932298 409
Equity−72 798−25 152
202020212022202320242025
Revenue778 1881 022 144
Operating result−49 598−642
Result before tax−58 658−11 278
Net result−58 6581 592
Total assets198 932298 409
Equity−72 798−25 152
Regnskapsregisteret · company_revenue · FY2025 (company)
register ledger · money
2026-07-22regaccounts_filed: sisteInnsendteAarsregnskap2024 -> 2025
owners
20242025
PINE Z CAPITAL AS
LONG CAPITAL AS 00
ELLA&COMPANY AS 00
BASSERN AS
STAALNACKE AS 00
KA INVEST & STYRE AS 0
202020212022202320242025
PINE Z CAPITAL AS 1
LONG CAPITAL AS 000000
ELLA&COMPANY AS 000000
BASSERN AS 0000
STAALNACKE AS 00
KA INVEST & STYRE AS 0
Aksjonærregisteret · company_ownership · 2025 · both directions
stewards
202420252026
auditor BDO AS 2026-06-23
accountant TORP ØKONOMI AS 2026-06-23
2020202120222023202420252026
auditor BDO AS 2026-06-23
accountant TORP ØKONOMI AS 2026-06-23
Brreg · company_org_roles
tenders
No recorded tender wins.
Relevant open tenders — matched · NACE 47.730 ↔ CPV
subscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
hiring
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
group · owns
Group revenue kr 1.02bnGroup net kr 1.59MTenders won 0Rolled up across the parent + 1 subsidiary — 995628953 alone is —.
rollup estimate · filed konsernregnskap not yet in Intelligo
100%
Aksjonærregisteret · company_ownership · 2025 · both directions
FY2025audit: No reservationsBDO AS87 full-time equivalentssigned: Jonas Petter Sundberg, Christian Jebsen, Marianne Kristine Arnesen Eskeland, Kristin Haram Førde, Silje Digerud, Henriette Hessen, Elisabeth Haug
Regnskapsregisteret (årsberetning) · company_annual_reports
22 notes from the report
Audit opinionBDO AS issued an unqualified audit opinion on the 2025 financial statements.“Vi har revidert arsregnskapet til Farmasiet AS.”
Audit opinionThe auditor states the board's report is consistent with the financial statements and contains required disclosures.“er konsistent med arsregnskapet og”
Going concernThe board confirms the accounts are prepared on a going concern basis despite negative equity.“Arsregnskapet er avlagt under forutsetning om fortsatt drift, og”
Going concernEquity is negative MNOK -25.2 but the board considers liquidity and equity sufficient at 31.12.25.“Egenkapitalen er MNOK-25,2 per 31.12.25.Selskapet har ingen lanevilkar knyttet til egenkapital og den”
OwnershipVerdane Capital X Cordelia Co-Invest AB holds 96.1 % of the shares.“Verdane Capitazl XCordelia Co-lnvest AB 349 203 1 849 231 2 198 434 96,1%”
Share capitalShare capital consists of ordinary shares and preference shares, total 2 263 762 shares.“Aksjekapitalen f Farmasiet AS pr 31.12 bestar av”
RemunerationSalary to the daglig leder was 3 314 164; total remuneration 3 478 388 and board fees 800 000.“Lonn 3 314 164 o”
Related partyNo loans or security have been given to the CEO, chair or other related parties.“Det erfkke gitt lan/sikkerhetsstillelse til daglig leder, styrets leder eller andre naerstaende parter.”
Related partyA group contribution receivable of 58 500 000 from Verdane Capital X Cordelia Co-Invest AB.“Fordring pa Verdane Capital X Cordelia Co-lnvest AB 58 500 000”
Related partyThe improvement in equity is due to a group contribution received in 2025.“i egenkapital skyldes mottatt konsernbidrag i 2025.”
Pledge or guaranteeBook value of pledged assets (inventory, fixed assets, receivables) totalled 221 777 987.“Sum 221 777 987 133 966 914”
Loan or financingBank loan agreement contains covenants on revenue growth, liquidity and interest coverage, all met at 31.12.25.“Deterstiltcovenantskravilaneavtalenmellomselskapetogbanken,sominneholderblant annet”
Loan or financingMNOK 85.9 in liquidity and available credit facilities, with dialogue with the existing owner on further financing if needed.“god dialog med eksisterendeeier om ytterligerefinansiering dersom detskulle oppsta behovfor dette.”
Staff numbersAverage full-time equivalents were 87 in 2025 (83 in 2024).“Gjennomsnittlig antall arsverk sysselsatt iregnskapsaret 87 83”
DividendThe 2025 profit of 1 592 110 was transferred to other equity; no dividend proposed.“Avsatt til annen egenkapital 1 592 110 0”
Deferred taxNet deferred tax asset, including a loss carryforward of 308 747 723, is not capitalised.“I henhold til god regnskapsskikk balansefores ikke utsatt skattefordel.”
Capitalised R&DMNOK 7.8 (4.7) of development work on prescription systems, automation and digital customer solutions was capitalised as intangible assets in 2025.“Deteri2025balansefortMNoK7.8(4,7)somimmaterielleeiendeler”
Post balance sheet eventNo events have occurred after year-end that are not reflected in the accounts and are material to the assessment of results and position.“Det harikke oppstatt forhold som detikke ertatthensyntiliarsregnskapetog someravvesentlig”
OtherRevenue passed NOK 1 billion for the first time in 2025.“Passerteenmilliardkroneriomsetning.”
OtherAuditor fees for 2025 amounted to NOK 368 047 excluding VAT.“Palept honorar til revisor for 2025 utgjor kr 368 047,- eksl.mva.”
OtherThe company has taken out directors' and officers' liability insurance with RiskPoint.“Selskapethartegnetforsikringforstyremedlemmenesogledelsens”
OtherThe defined benefit pension scheme covers 27 people through Statens Pensjonskasse.“Selskapetharenytelsesordning somomfatterialt27personer.”
register
registered 2014-03-17
Brreg · companies
register ledger · 20 events · 10 series/meta rows folded into the charts
2026-08-13regemployees_change: employees132 -> 134
2026-07-25regemployees_change: employees128 -> 132
2026-07-22regaccounts_filed: sisteInnsendteAarsregnskap2024 -> 2025
2026-07-17regemployee_change: antallAnsatte128 -> 132
2026-06-16regemployee_change: antallAnsatte125 -> 128
2026-05-14regemployee_change: antallAnsatte119 -> 125
2026-04-16regemployee_change: antallAnsatte118 -> 119
2026-03-13regemployee_change: antallAnsatte115 -> 118
2025-12-31reportAudit opinionBDO AS issued an unqualified audit opinion on the 2025 financial statements. — Vi har revidert arsregnskapet til Farmasiet AS.
2025-12-31reportAudit opinionThe auditor states the board's report is consistent with the financial statements and contains required disclosures. — er konsistent med ...
2025-12-31reportGoing concernThe board confirms the accounts are prepared on a going concern basis despite negative equity. — Arsregnskapet er avlagt under forutsetni...
2025-12-31reportGoing concernEquity is negative MNOK -25.2 but the board considers liquidity and equity sufficient at 31.12.25. — Egenkapitalen er MNOK-25,2 per 31.12...
2025-12-31reportOwnershipVerdane Capital X Cordelia Co-Invest AB holds 96.1 % of the shares. — Verdane Capitazl XCordelia Co-lnvest AB 349 203 1 849 231 2 198 ...
2025-12-31reportShare capitalShare capital consists of ordinary shares and preference shares, total 2 263 762 shares. — Aksjekapitalen f Farmasiet AS pr 31.12 bestar av
2025-12-31reportRemunerationSalary to the daglig leder was 3 314 164; total remuneration 3 478 388 and board fees 800 000. — Lonn 3 314 164 o
2025-12-31reportRelated partyNo loans or security have been given to the CEO, chair or other related parties. — Det erfkke gitt lan/sikkerhetsstillelse til daglig led...
2025-12-31reportRelated partyA group contribution receivable of 58 500 000 from Verdane Capital X Cordelia Co-Invest AB. — Fordring pa Verdane Capital X Cordelia Co-l...
2025-12-31reportRelated partyThe improvement in equity is due to a group contribution received in 2025. — i egenkapital skyldes mottatt konsernbidrag i 2025.
2025-12-31reportPledge or guaranteeBook value of pledged assets (inventory, fixed assets, receivables) totalled 221 777 987. — Sum 221 777 987 133 966 914
2025-12-31reportLoan or financingBank loan agreement contains covenants on revenue growth, liquidity and interest coverage, all met at 31.12.25. — Deterstiltcovenantskrav...
Skiwo · company_events